肝硬変におけるヒトの腸内微生物の変化
Nan Qin1, Fengling Yang2, Ang Li2
11] State Key Laboratory for Diagnosis and Treatment of Infectious Disease, The First Affiliated Hospital, College of Medicine, Zhejiang University, 310003 Hangzhou, China [2] Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, 310003 Hangzhou, China [3].
Nature
|August 1, 2014
まとめ
この研究は,肝硬変患者における重要な腸内微生物の変化を明らかにし,特定の細菌遺伝子を特定し,口腔細菌の侵入を示唆しています. これらの発見は,新しい微生物群バイオマーカーを使用して正確な診断を可能にします.
科学分野:
- 微生物学 微生物学とは
- 胃腸内科 胃腸内科
- ゲノミクスゲノミクスとは
背景:
- 肝硬変は,世界的な慢性肝疾患の深刻な結果です.
- 肝硬変における腸内微生物群の役割を理解することは,疾患管理において極めて重要です.
研究 の 目的:
- 肝硬変患者の腸内微生物の組成を特徴付けるために.
- 肝硬変の診断のための新しい微生物バイオマーカーを特定する.
主な方法:
- 98人の肝硬変患者と83人の健康な対照群における腸内微生物群の比較メタゲノミクス分析.
- 総合的なコホート固有の遺伝子セットの構築.
- 特定されたバイオマーカーに基づく診断指標の開発と検証.
主要な成果:
- 2,6900万の遺伝子のリファレンス遺伝子セットが確立され,その36.1%が新種の遺伝子であった.
- 患者と対照群の間で75,245の異なった豊富な遺伝子が特定されました.
- 54%の患者によって濃縮された種は口から発生し,口から腸への転移を示しています.
結論:
- 腸内微生物群のディスバイオシスは肝硬変の特徴である.
- 微生物群を標的にしたバイオマーカーは,正確な早期の疾患診断のための有望な道を提供します.
- 特定されたバイオマーカーは,2型糖尿病や炎症性腸疾患などの他の状態から肝硬変を区別することができます.
関連する概念動画
Cirrhosis I: Introduction
25
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
25
Cirrhosis II: Pathophysiology
33
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
33
Development of Human Microbiota
60
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
60
Microbiota of the Large Intestine
94
The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
94
Introduction to the Human Microbiota
162
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
162
Functions of the Gut Microbiota
145
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
145


